A critical advance in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial tumor suppressor protein is frequently disabled in several kinds of malignancies, leading https://guidemysocial.com/story7460841/mini-antibodies-restore-the-p53-protein-new-promising-approach-for-cancer-therapy